0000724004-26-000020
SEC filingMesa Laboratories, Inc. filed a Form 8-K on March 9, 2026, disclosing matters under Item 5.02 related to CEO departure and election or appointment of certain officers, including compensatory arrangements, as well as Item 7.01 referencing Exhibit 99.1. Exhibit 10.1 is an Employment Agreement dated March 3, 2026, with Siddhartha Kadia.